Stoker N G, Fairweather N F, Spratt B G
Gene. 1982 Jun;18(3):335-41. doi: 10.1016/0378-1119(82)90172-x.
Small low-copy-number plasmid vectors were constructed by in vitro and in vivo recombinant DNA techniques. pLG338 and pLG339 are derived from pSC105, have a copy number of six to eight per chromosome, and carry genes conferring resistance to tetracycline and kanamycin. pLG338 (7.3 kb) has unique restriction endonuclease sites for BamHI, SalI, HincII, SmaI, XhoI, EcoRI and KpnI, the first five lying within a drug resistance gene. pLG339 (6.2 kb) lacks the KpnI site, but has unique SphI and PvuII sites. These versatile vectors should be useful for cloning many genes coding for membrane and regulatory proteins which cannot be cloned into high-copy-number plasmids.
通过体外和体内重组DNA技术构建了小的低拷贝数质粒载体。pLG338和pLG339源自pSC105,每条染色体的拷贝数为6至8个,并携带赋予四环素和卡那霉素抗性的基因。pLG338(7.3 kb)具有BamHI、SalI、HincII、SmaI、XhoI、EcoRI和KpnI的独特限制性内切酶位点,前五个位于耐药基因内。pLG339(6.2 kb)缺少KpnI位点,但具有独特的SphI和PvuII位点。这些多功能载体对于克隆许多编码不能克隆到高拷贝数质粒中的膜蛋白和调节蛋白的基因应该是有用的。